Search

Search Constraints

Start Over Filtering by: Keyword T-CELLS Remove constraint Keyword: T-CELLS

Search Results

  • Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections
  • Knife's edge: Balancing immunogenicity and reactogenicity in mRNA vaccines
  • Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022)
  • Brain microglia serve as a persistent HIV reservoir despite durable antiretroviral therapy
  • HIV, asymptomatic STI, and the rectal mucosal immune environment among young men who have sex with men
  • Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer
  • Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results
  • The magic of small-molecule drugs during ex vivo expansion in adoptive cell therapy
  • Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis
  • Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer
  • The roles of thermal and mechanical stress in focused ultrasound-mediated immunomodulation and immunotherapy for central nervous system tumors
  • Soluble TNF mediates amyloid-independent, diet-induced alterations to immune and neuronal functions in an Alzheimer's disease mouse model
  • Multicolor Light-Induced Immune Activation via Polymer Photocaged Cytokines
  • Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium
  • CD8(+) lymphocytes do not impact SIV reservoir establishment under ART
  • Recombinant GPEHT Fusion Protein Derived from HTLV-1 Proteins with Alum Adjuvant Induces a High Immune Response in Mice
  • Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus
  • Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections
  • Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression
  • A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186
  • Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study
  • Analysis of Cross-sectional and Longitudinal HLA and Anti-viral Responses After COVID Infection in Renal Allograft Recipients: Differences and Correlates
  • Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens
  • Lactobacillus rhamnosus attenuates bone loss and maintains bone health by skewing Treg-Th17 cell balance in Ovx mice
  • High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival
  • Engineering a Therapeutic Protein to Enhance the Study of Anti-Drug Immunity
  • A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model
  • Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
  • Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
  • Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women
  • IFN-gamma signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS
  • PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques
  • STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer
  • PDL1 expression on monocytes is associated with plasma cytokines in Tuberculosis and HIV
  • Lactobacillus rhamnosus GG Orchestrates an Antitumor Immune Response
  • Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling
  • Combined protein and transcript single-cell RNA sequencing in human peripheral blood mononuclear cells
  • Dual role of endothelial Myct1 in tumor angiogenesis and tumor immunity
  • Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia
  • Systematic Assessment of Antiviral Potency, Breadth, and Synergy of Triple Broadly Neutralizing Antibody Combinations against Simian-Human Immunodeficiency Viruses
  • Oral Vaccination Approaches for Anti-SHIV Immunity
  • Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients
  • Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors
  • Intrinsic antiviral immunity of barrier cells revealed by an iPSC-derived blood-brain barrier cellular model
  • Article Distinct phenotypic states and spatial distribution of CD8(+ )T cell clonotypes in human brain metastases
  • Inhibition of Inflammation and iNOS Improves Lymphatic Function in Obesity
  • A critical role for the programmed death ligand 1 in fetomaternal tolerance
  • Lymph node CXCR5(+) NK cells associate with control of chronic SHIV infection
  • Defining Discriminatory Antibody Fingerprints in Active and Latent Tuberculosis
  • IL-21 and IFN alpha therapy rescues terminally differentiated NK cells and limits SIV reservoir in ART-treated macaques
  • Brief exposure to hyperglycemia activates dendritic cells in vitro and in vivo
  • Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model
  • Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy
  • Evolving Role of Immunotherapy in Advanced Biliary Tract Cancers
  • Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy
  • The microbiome and the immune system in critical illness
  • The Roles of IL-22 and Its Receptor in the Regulation of Inflammatory Responses in the Brain
  • Synthetic biomarkers: a twenty-first century path to early cancer detection
  • Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection
  • The microbiome restrains melanoma bone growth by promoting intestinal NK and Th1 cell homing to bone
  • Indole derivatives, microbiome and graft versus host disease
  • A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity
  • Preexisting malignancy abrogates the beneficial effects of CXCR4 blockade during sepsis
  • Innate inflammation drives NK cell activation to impair Treg activity
  • Vaccine-related major cutaneous reaction size correlates with cellular-mediated immune responses after tularaemia immunisation
  • Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study
  • Ex vivo rectal explant model reveals potential opposing roles of Natural Killer cells and Marginal Zone-like B cells in HIV-1 infection
  • Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapy
  • The Immune Response to Eastern Equine Encephalitis Virus Acquired Through Organ Transplantation
  • Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report
  • Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4(+)T cell decline and increased immune activation during acute infection
  • HIV and the tuberculosis "set point": how HIV impairs alveolar macrophage responses to tuberculosis and sets the stage for progressive disease
  • Phase 1 safety and pharmacodynamic study of lenalidomide combined with everolimus in patients with advanced solid malignancies with efficacy signal in adenoid cystic carcinoma
  • Caspase-8 restricts natural killer cell accumulation during MCMV Infection
  • Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells
  • HIV Is Associated with Modified Humoral Immune Responses in the Setting of HIV/TB Coinfection
  • CD28-Dependent CTLA-4 Expression Fine-Tunes the Activation of Human Th17 Cells
  • Mechanisms of reactivation of latent tuberculosis infection due to SIV coinfection
  • Innate, non-cytolytic CD8(+)T cell-mediated suppression of HIV replication by MHC-independent inhibition of virus transcription
  • TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity
  • Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL
  • Bivalent Carbohydrate Binding Is Required for Biological Activity of Clitocybe nebularis Lectin (CNL), the N, N '-Diacetyllactosediamine (GalNAc beta 1-4GlcNAc, LacdiNAc)-specific Lectin from Basidiomycete C. nebularis
  • IL-17, IL-27, and IL-33: A Novel Axis Linked to Immunological Dysfunction During Sepsis
  • Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome
  • Correlation Patterns Among B7 Family Ligands and Tryptophan Degrading Enzymes in Hepatocellular Carcinoma
  • Progress in defining CD4 helper cell responses in chronic viral infections
  • Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy
  • Perturbation of Transcription Factor Nur77 Expression Mediated by Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  • Interleukin 9 alterations linked to alzheimer disease in african americans
  • Crossroads of Cancer and HIV-1: Pathways to a Cure for HIV
  • A(2B)AR expression in non-immune cells plays an important role in the development of murine colitis
  • A simultaneous oral and intramuscular prime/sublingual boost with a DNA/Modified Vaccinia Ankara viral vector-based vaccine induces simian immunodeficiency virus-specific systemic and mucosal immune responses in juvenile rhesus macaques
  • Molecular factors in dendritic cell responses to adsorbed glycoconjugates
  • If it is methylated it must be Tectonic
  • Pluripotent Stem Cells: Immune to the Immune System?
  • An Anti-CD154 Domain Antibody Prolongs Graft Survival and Induces FoxP3(+) iTreg in the Absence and Presence of CTLA-4 Ig
  • Deciphering how HIV-1 weakens and cracks the bone
  • The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90
  • Genotype-Dependent Effects of TGF-beta 1 on Mast Cell Function: Targeting the Stat5 Pathway
  • Unbiased transcriptomic analyses reveal distinct effects of immune deficiency in CNS function with and without injury